Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-006724
Filing Date
2017-02-01
Accepted
2017-02-01 16:38:12
Documents
1
Period of Report
2017-01-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3562
  Complete submission text file 0001209191-17-006724.txt   5123
Mailing Address 10505 ROSELLE STREET SAN DIEGO CA 92121
Business Address
HENNEY CHRISTOPHER S (Reporting) CIK: 0001242880 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33882 | Film No.: 17565384

Mailing Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121
Business Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121 (206) 801-2100
Cascadian Therapeutics, Inc. (Issuer) CIK: 0001412067 (see all company filings)

EIN.: 260868560 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research